63 research outputs found
THC exposure during adolescence does not modify nicotine reinforcing effects and relapse in adult male mice.
Rationale: Cannabis use is typically initiated during adolescence, and different studies suggest that adolescent cannabinoid exposure may increase the risk for drug addiction in adulthood.
Objectives: This study investigated the effects of adolescent exposure to the main psychoactive component of cannabis, Δ9-tetrahydrocannabinol (THC), in the reinforcing properties of nicotine in adult male mice. Possible alterations in relapse to nicotine-seeking behaviour in adult animals due to THC adolescent exposure were also evaluated.
Methods: Adolescent mice were exposed to escalating doses of THC from PND35 to PND49. When mice reached adulthood (PND70), surgical procedures were applied for further behavioural evaluation. Nicotine self-administration sessions were conducted consecutively for 10 days. Following extinction, mice were tested for cue- and stress-induced reinstatement of nicotine-seeking behaviour.
Results: Adolescent THC treatment did not modify acquisition and extinction of nicotine self-administration in adulthood. Moreover, THC exposure did not alter relapse to nicotine seeking induced by stress or nicotine-associated cues.
Conclusions: These results suggest that a history of exposure to THC during adolescence under these particular conditions does not modify the reinforcing effects and seeking behaviour of nicotine in the adult period.pre-print256 K
When Orexins Meet Cannabinoids: Bidirectional Functional Interactions.
A growing body of evidence suggests the existence of biochemical and functional interactions between the endocannabinoid and orexin systems. Cannabinoid and orexin receptors have been shown to form heterodimers in agreement with the overlapping distribution of both receptors in several brain areas, and the activation of common intracellular signaling pathways, such as the MAP kinase cascade. The activation of orexin receptors induces the synthesis of the endocannabinoid 2-arachidonoyl glycerol suggesting that the endocannabinoid system participates in some physiological functions of orexins. Indeed, functional interactions between these two systems have been demonstrated in several behavioral responses including nociception, reward and food intake. The present review is focused on the latest developments in cannabinoid-orexin cross-modulation and the implications of this interesting interaction.pre-print455 K
Facilitation of Contextual Fear Extinction by Orexin-1 Receptor Antagonism Is Associated with the Activation of Specific Amygdala Cell Subpopulations.
Background: Orexins are hypothalamic neuropeptides recently involved in the regulation of emotional memory. The basolateral
amygdala, an area orchestrating fear memory processes, appears to be modulated by orexin transmission during fear extinction.
However, the neuronal types within the basolateral amygdala involved in this modulation remain to be elucidated.
Methods: We used retrograde tracing combined with immunofluorescence techniques in mice to identify basolateral amygdala
projection neurons and cell subpopulations in this brain region influenced by orexin transmission during contextual fear
extinction consolidation.
Results: Treatment with the orexin-1 receptor antagonist SB334867 increased the activity of basolateral amygdala neurons
projecting to infralimbic medial prefrontal cortex during fear extinction. GABAergic interneurons expressing calbindin, but
not parvalbumin, were also activated by orexin-1 receptor antagonism in the basolateral amygdala.
Conclusions: These data identify neuronal circuits and cell populations of the amygdala associated with the facilitation of
fear extinction consolidation induced by the orexin-1 receptor antagonist SB334867.post-print1256 K
New Insights in the Involvement of the Endocannabinoid System and Natural Cannabinoids in Nicotine Dependence.
Nicotine, the main psychoactive component in tobacco smoke, plays a major role in
tobacco addiction, producing a high morbidity and mortality in the world. A great amount of
research has been developed to elucidate the neural pathways and neurotransmitter systems
involved in such a complex addictive behavior. The endocannabinoid system, which has been
reported to participate in the addictive properties of most of the prototypical drugs of abuse, is also
implicated in nicotine dependence. This review summarizes and updates the main behavioral and
biochemical data involving the endocannabinoid system in the rewarding properties of nicotine as
well as in nicotine withdrawal and relapse to nicotine‐seeking behavior. Promising results from
preclinical studies suggest that manipulation of the endocannabinoid system could be a potential
therapeutic strategy for treating nicotine addiction.post-print641 K
CB2 cannabinoid receptor expression is increased in 129S1/SvImJ mice: behavioral consequences.
Genetic and environmental factors are implicated in the etiology of neuropsychiatric diseases. Inbred mouse strains, including the 129S1/SvImJ (S1), constitute important models to study the influence of genetic factors in these conditions. S1 mice displayed anxiogenic-like behavior, impaired fear extinction, and increased prepulse inhibition (PPI) of startle reflex compared to C57BL/6J (BL6) mice. Given the role played by the endocannabinoid system (ECS) in these responses, we evaluated the expression of the ECS components in different brain regions in S1 mice. Gene expression levels of the cannabinoid type-1 and type-2 receptors (CB1R and CB2R) and the endocannabinoid metabolizing enzymes varied depending on the brain region evaluated. Notably, CB2R expression markedly increased in the amygdala, prefrontal cortex and hippocampus in S1 mice. Moreover, CB2R blockade with SR144528 partially rescued the anxiogenic phenotype in S1 mice, while CB2R activation with JWH133 potentiated the deficits in fear extinction and the PPI of startle reflex in this mouse strain. These data suggest that CB2R is involved in the behavioral alterations observed in S1 mice and underline the importance of this cannabinoid receptor subtype in the regulation of certain central nervous system disorders.post-print1604 K
An Investigation of Interactions Between Hypocretin/Orexin Signaling and Glutamate Receptor Surface Expression in the Rat Nucleus Accumbens Under Basal Conditions and After Cocaine Exposure
Hypocretin peptides are critical for the effects of cocaine on excitatory synaptic strength in the ventral tegmental area (VTA). However, little is known about their role in cocaine-induced synaptic plasticity in the nucleus accumbens (NAc). First, we tested whether hypocretin-1 by itself could acutely modulate glutamate receptor surface expression in the NAc, given that hypocretin-1 in the VTA reproduces cocaine\u27s effects on glutamate transmission. We found no effect of hypocretin-1 infusion on AMPA or NMDA receptor surface expression in the NAc, measured by biotinylation, either 30 min or 3h after the infusion. Second, we were interested in whether changes in hypocretin receptor-2 (Hcrtr-2) expression contribute to cocaine-induced plasticity in the NAc. As a first step towards addressing this question, Hcrtr-2 surface expression was compared in the NAc after withdrawal from extended-access self-administration of saline (control) versus cocaine. We found that surface Hcrtr-2 levels remain unchanged following 14, 25 or 48 days of withdrawal from cocaine, a time period in which high conductance GluA2-lacking AMPA receptors progressively emerge in the NAc. Overall, our results fail to support a role for hypocretins in acute modulation of glutamate receptor levels in the NAc or a role for altered Hcrtr-2 expression in withdrawal-dependent synaptic adaptations in the NAc following cocaine self-administration
Targeting the orexin/hypocretin system for the treatment of neuropsychiatric and neurodegenerative diseases: from animal to clinical studies
Orexins (also known as hypocretins) are neuropeptides located exclusively in hypothalamic neurons that have extensive projections throughout the central nervous system and bind two different G protein-coupled receptors (OX1R and OX2R). Since its discovery in 1998, the orexin system has gained the interest of the scientific community as a potential therapeutic target for the treatment of different pathological conditions. Considering previous basic science research, a dual orexin receptor antagonist, suvorexant, was the first orexin agent to be approved by the US Food and Drug Administration to treat insomnia. In this review, we discuss and update the main preclinical and human studies involving the orexin system with several psychiatric and neurodegenerative diseases. This system constitutes a nice example of how basic scientific research driven by curiosity can be the best route to the generation of new and powerful pharmacological treatments
Adolescent exposure to the Spice/K2 cannabinoid JWH-018 impairs sensorimotor gating and alters cortical perineuronal nets in a sex-dependent manner.
The consumption of synthetic cannabinoids during adolescence is reported to be a risk factor for the appearance of psychiatric disorders later in life. JWH-018 was identified as one of the primary psychoactive components present in Spice/K2 preparations. This study evaluated the short- and long-term consequences of exposure to JWH-018 during the adolescence in anxiety-like behavior, fear extinction, and sensorimotor gating in male and female mice. Alterations in anxiety varied depending on the time interval between treatment and behavioral analysis along with sex, while no changes were observed in the extinction of fear memory. A decrease in prepulse inhibition of the startle reflex was revealed in male, but not female, mice at short- and long-term. This behavioral disturbance was associated with a reduction in the number of perineuronal nets in the prelimbic and infralimbic regions of the prefrontal cortex in the short-term. Furthermore, adolescent exposure to JWH-018 induced an activation of microglia and astrocytes in the prefrontal cortex of male mice at both time intervals. A transitory decrease in the expression of GAD67 and CB2 cannabinoid receptors in the prefrontal cortex was also found in male mice exposed to JWH-018. These data reveal that the treatment with JWH-018 during the adolescence leads to long-lasting neurobiological changes related to psychotic-like symptoms, which were sex-dependent.post-print2490 K
Amygdalar CB2 cannabinoid receptor mediates fear extinction deficits promoted by orexin-A/hypocretin-1.
Anxiety and stress disorders are often characterized by an inability to extinguish learned fear responses. Orexins/
hypocretins are involved in the modulation of aversive memories, and dysregulation of this system may
contribute to the aetiology of anxiety disorders characterized by pathological fear. The mechanisms by which
orexins regulate fear are unknown. Here we investigated the role of the endogenous cannabinoid system in the
impaired fear extinction induced by orexin-A (OXA) in male mice. The selective inhibitor of 2-arachidonoylglycerol
(2-AG) biosynthesis O7460 abolished the fear extinction deficits induced by OXA. Accordingly, increased 2-
AG levels were observed in the amygdala and hippocampus of mice treated with OXA that do not extinguish fear,
suggesting that high levels of this endocannabinoid are related to poor extinction. Impairment of fear extinction
induced by OXA was associated with increased expression of CB2 cannabinoid receptor (CB2R) in microglial cells
of the basolateral amygdala. Consistently, the intra-amygdala infusion of the CB2R antagonist AM630 completely
blocked the impaired extinction promoted by OXA. Microglial and CB2R expression depletion in the amygdala
with PLX5622 chow also prevented these extinction deficits. These results show that overactivation of the orexin
system leads to impaired fear extinction through 2-AG and amygdalar CB2R. This novel mechanism could be of
relevance for the development of novel potential approaches to treat diseases associated with inappropriate
retention of fear, such as post-traumatic stress disorder, panic anxiety and phobias.post-print3418 K
Endocannabinoid Regulation of Acute and Protracted Nicotine Withdrawal: Effect of FAAH Inhibition
Evidence shows that the endocannabinoid system modulates the addictive properties of nicotine. In the present study, we hypothesized that spontaneous withdrawal resulting from removal of chronically implanted transdermal nicotine patches is regulated by the endocannabinoid system. A 7-day nicotine dependence procedure (5.2 mg/rat/day) elicited occurrence of reliable nicotine abstinence symptoms in Wistar rats. Somatic and affective withdrawal signs were observed at 16 and 34 hours following removal of nicotine patches, respectively. Further behavioral manifestations including decrease in locomotor activity and increased weight gain also occurred during withdrawal. Expression of spontaneous nicotine withdrawal was accompanied by fluctuation in levels of the endocannabinoid anandamide (AEA) in several brain structures including the amygdala, the hippocampus, the hypothalamus and the prefrontal cortex. Conversely, levels of 2-arachidonoyl-sn-glycerol were not significantly altered. Pharmacological inhibition of fatty acid amide hydrolase (FAAH), the enzyme responsible for the intracellular degradation of AEA, by URB597 (0.1 and 0.3 mg/kg, i.p.), reduced withdrawal-induced anxiety as assessed by the elevated plus maze test and the shock-probe defensive burying paradigm, but did not prevent the occurrence of somatic signs. Together, the results indicate that pharmacological strategies aimed at enhancing endocannabinoid signaling may offer therapeutic advantages to treat the negative affective state produced by nicotine withdrawal, which is critical for the maintenance of tobacco use
- …